EUVIMEDEUVIMED entdecken
Crossref

Incidence of Autoimmune Rheumatic Diseases Following COVID-19 Infection

Mandana Khodashahi, Maryam Sahebari, Zahra Rezaieyazdi, Mohammad Basil Al-Obaidi, Masoumeh Salari, Rozita Khodashahi, Zahra Mirfeizi, Hassan Mehrad Majd, Muhammed Joghatayi

Journal of Iranian Medical Council · 11.04.2026

DOI: 10.18502/jimc.v9i2.21177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Iranian Medical Council, online erschienen am 11.04.2026. Verfasst von Mandana Khodashahi und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The relationship between COVID-19 and autoimmune rheumatic diseases remains complex, with growing evidence suggesting that severe COVID-19 may trigger or exacerbate autoimmune rheumatic diseases. This study aimed to assess the prevalence of AIRDs following COVID-19 infection and identify factors associated with their onset.

Methods

A total of 183 patients diagnosed with Autoimmune Rheumatic Diseases (AIRDs) within 30 days post-COVID-19 were evaluated. Data were collected on demographics, comorbidities, disease severity, and inflammatory markers. Cox and logistic regression analyses were conducted to assess risk factors associated with AIRD development.

Results

The findings indicate a notable link between severe COVID-19 and the onset of AIRDs, with higher inflammatory markers significantly associated with increased risk. Interestingly, hypothyroidism appeared to have a protective effect, potentially due to the immunomodulatory effects of treatments like levothyroxine. These findings align with some literature suggesting an immune dysregulation following COVID-19. Despite the insights, the cross-sectional design of the study limits the ability to establish causality.

Conclusion

This study underscores the significant role of severe COVID-19 and elevated inflammatory markers in the development of AIRDs. The protective effect of hypothyroidism could open avenues for future therapeutic considerations. Further, longitudinal studies are essential to better understand the mechanisms driving these associations and explore interventions aimed at reducing AIRD risk in post-COVID-19 patients.

Zitieren

APA

Khodashahi, M., Sahebari, M., Rezaieyazdi, Z., Al-Obaidi, M. B., Salari, M., Khodashahi, R., Mirfeizi, Z., Majd, H. M., & Joghatayi, M. (2026). Incidence of Autoimmune Rheumatic Diseases Following COVID-19 Infection. Journal of Iranian Medical Council. https://doi.org/10.18502/jimc.v9i2.21177

Vancouver

Khodashahi M, Sahebari M, Rezaieyazdi Z, Al-Obaidi MB, Salari M, Khodashahi R, et al. Incidence of Autoimmune Rheumatic Diseases Following COVID-19 Infection. Journal of Iranian Medical Council. 2026. doi:10.18502/jimc.v9i2.21177

BibTeX
@article{Khodashahi2026,
  author = {Khodashahi, Mandana and Sahebari, Maryam and Rezaieyazdi, Zahra and Al-Obaidi, Mohammad Basil and Salari, Masoumeh and Khodashahi, Rozita and Mirfeizi, Zahra and Majd, Hassan Mehrad and Joghatayi, Muhammed},
  title = {Incidence of Autoimmune Rheumatic Diseases Following COVID-19 Infection},
  journal = {Journal of Iranian Medical Council},
  year = {2026},
  doi = {10.18502/jimc.v9i2.21177}
}
Kostenlos starten →